Product NDC: | 50474-599 |
Proprietary Name: | Keppra |
Non Proprietary Name: | levetiracetam |
Active Ingredient(s): | 750 mg/1 & nbsp; levetiracetam |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50474-599 |
Labeler Name: | UCB, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022285 |
Marketing Category: | NDA |
Start Marketing Date: | 20090401 |
Package NDC: | 50474-599-66 |
Package Description: | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50474-599-66) |
NDC Code | 50474-599-66 |
Proprietary Name | Keppra |
Package Description | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50474-599-66) |
Product NDC | 50474-599 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | levetiracetam |
Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20090401 |
Marketing Category Name | NDA |
Labeler Name | UCB, Inc. |
Substance Name | LEVETIRACETAM |
Strength Number | 750 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |